ProCE Banner Activity

Advanced Renal Cell Carcinoma: Immunotherapy and Immunotherapy-Based Combinations


Slides featuring data and expert perspectives on immunotherapy and immunotherapy-based combinations for patients with advanced or metastatic renal cell carcinoma.

Released: June 07, 2023



Eric Jonasch

Eric Jonasch, MD

Professor, Department of GU Medical Oncology
UT MD Anderson Cancer Center 
Houston, Texas

Brian Rini

Brian Rini, MD, FASCO

Chief of Clinical Trials 
Division of Hematology/Oncology 
Vanderbilt University Medical Center
Nashville, Tennesee 

Tian Zhang

Tian Zhang, MD, MHS

Associate Professor
Genitourinary Oncology and Multi-Disease Precision Oncology Programs
Division of Hematology and Oncology
Department of Internal Medicine
UT Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb